Get more Mail & Guardian
Subscribe or Login.

New vaccine set to greatly reduce prevalence of shingles

Nine out of ten adults are at risk of developing shingles, a viral infection that causes a painful rash. It is caused by the same virus that causes chicken pox.

But now there is relief for South Africans who suffer from the condition: a shingles-specific vaccine has recently been introduced in the country.

Studies show that the vaccine – only for people older than 50 – can prevent the development of shingles in up to seven out of 10 people who would have got it had they not been vaccinated. The vaccine significantly reduces the occurrence or severity of pain for individuals who do get shingles.

“Anyone who has had chickenpox is at risk of getting shingles,” says Dr Allison Glass, a specialist virologist at Lancet laboratories. “The immune system can suppress and keep the virus under control for many years, but with time and as one gets older, there is a decline in natural immunity and the virus can flair up again, presenting as shingles.”

The risk of shingles increases as one gets older and the likelihood of persistent pain increases dramatically after the age of 50. Pain levels can vary in intensity from mild to severe, where even a light touch or mere breeze crossing the skin can be unbearable.


“Patients describe the pain of shingles in different ways, often as severe and excruciating. Typically it is described as a burning sensation,” says Dr Jody Pearl, a neurologist in private practice in Johannesburg. “Once the pain starts, the impact on your life can be devastating.”

Severe pain
Dr Milton Raff is the director of the Christian Barnard Memorial Hospital Pain Clinic in Cape Town and specialises in treating chronic pain.

“The problem with shingles-related pain,” he says, “is that it is so difficult to treat. Because it is pain resulting from affected nerves that function abnormally, regular pain medications are not effective. We only have a few specialised medications we can try. If these prove to be ineffective, then the pain can be incapacitating. In a small proportion of patients, the pain never goes away. Not only does the patient suffer severe pain, they can often not perform routine everyday tasks.”

Subscribe to the M&G

These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever.

The Mail & Guardian is a proud news publisher with roots stretching back 35 years, and we’ve survived right from day one thanks to the support of readers who value fiercely independent journalism that is beholden to no-one. To help us continue for another 35 future years with the same proud values, please consider taking out a subscription.

Related stories

Advertising

Subscribers only

Khoikhoi versus US giant Amazon

The controversial River Club development gets the go-ahead, but opponents say they are heading for court

SIU moves on eThekwini housing scam

The developer allegedly secured illegal funding from the housing regulatory authority

More top stories

Why South Africa stopped making vaccines

The high demand for Covid vaccines means there is a limited global supply. Local manufacturing is one solution. So why isn’t South Africa making its own jabs?

‘He can’t just write letters out of anger’: Mantashe reacts...

That is not how decisions are made in an organisation, the party’s national chairperson warns as Magashule sends suspension letter to Ramaphosa

Hlophe’s attorney found in contempt of court

The high court said Barnabas Xulu acted with impunity and contempt in the saga of getting him to repay millions in state funds

Aced: ANC secretary general suspended from the party for the...

Magashule is barred from carrying out his tasks and cannot talk on behalf of the party
Advertising

press releases

Loading latest Press Releases…
×